The new test, available as a Lab Service throughout Europe and US, leverages the Gold Standard CELLSEARCH platform to enumerate Circulating Multiple Myeloma Cells from blood and offers real-time standardized monitoring of multiple myeloma in clinical research studies.
Topics: CELLSEARCH, Multiple myeloma, CMMCs, Lab Services
CELLMAG – a cost effective, manual and simple approach for the enrichment and staining of extremely rare cells from blood
Topics: CTCs, CELLSEARCH, Liquid biopsy, Blood Enrichment, CellMag
Results presented at the 2020 San Antonio Breast Cancer Symposium confirm the relevance of screening for HER2+ CTCs from blood samples in patients with a HER2 negative primary tumor biopsy to optimize treatment strategy and patient outcome
Topics: CELLSEARCH, metastatic breast cancer, HER2, San Antonio Breast Cancer Symposium, CTC phenotyping
Robust pooled analysis demonstrating how CTC count may help to optimize treatment choices
Topics: CELLSEARCH, metastatic breast cancer, global pooled analysis, San Antonio Breast Cancer Symposium
First randomized clinical trial demonstrating that CTC count may help personalize treatment choices
Topics: CELLSEARCH, metastatic breast cancer, STIC
Researchers Use Menarini’s Liquid Biopsy Technology to Find Genetic Alterations in Cancer Cells that May Improve Prognosis and Treatment
Topics: CELLSEARCH, metastatic breast cancer, Multiple myeloma, HER2, AACR
Strategic partnership will focus on commercializing CELLSEARCH platform for
COVID-19 related use cases, along with other COVID-19 related products
Topics: CELLSEARCH, COVID-19, OpGEN
06/11/2020
The test detects antibodies made by the immune system in response to infection by the novel coronavirus in as little as 10 minutes
Topics: COVID-19, Coronavirus, COVID-19 Ab test, SARS-CoV-2, diagnostic
Results from prospective trials show a "clear prognostic value" for CTC counts
Topics: CTCs, CELLSEARCH, metastatic breast cancer, prostate cancer, ASCO
04/27/2020
Enumeration of Circulating Endothelial Cells (CECs) with CELLSEARCH platform may offer a new tool for investigating the role of the damaged endothelium in SARS-CoV-2 infection and clinical manifestation.
Topics: CELLSEARCH, COVID-19, CECs, Coronavirus, Circulating Endothelial Cells
©2020 Menarini Silicon Biosystems. All rights reserved. This site is published by Menarini Silicon Biosystems which is solely responsible for its contents.
The products/services discussed are for research use only and not for use in diagnostic procedures (except as specifically noted).
